Showing results (991-1000 of 1,566) with videos related to
Sort By:
Pageof 157
Asia-Pacific Journal of Clinical Oncology|September 7, 2020
Neurological immune-related adverse events associated with immune checkpoint inhibitors: A review of the literatureSiyuan Fan, Haitao Ren, Luo Zhao, et al.Asia-Pacific Journal of Clinical Oncology|September 7, 2020
Financial toxicity in patients with cancer attending a public Australian tertiary hospital: A pilot studyLuke McLean, Wei Hong, Sue-Anne McLachlanAsia-Pacific Journal of Clinical Oncology|September 7, 2020
Radiation oncology during COVID-19: Strategies to avoid compromised carePatrick J Horsley, Michael Back, Gillian Lamoury, et al.Asia-Pacific Journal of Clinical Oncology|November 2, 2020
Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancerRichard de Boer, Rina Hui, Elgene Lim, et al.Asia-Pacific Journal of Clinical Oncology|February 12, 2020
Tissue factor pathway inhibitor 2 suppresses the growth of thyroid cancer cells through by induction of apoptosisYan Yang, Chen Zhang, Shu Li, et al.Asia-Pacific Journal of Clinical Oncology|November 7, 2019
Hematological toxicities associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyEvelyn Y T Wong, Grace H C Tan, Mrinal Kumar, et al.Asia-Pacific Journal of Clinical Oncology|February 8, 2020
Increasing Tim-3+CD244+, Tim-3+CD57+, and Tim-3+PD-1+ T cells in patients with acute myeloid leukemiaJiaxiong Tan, Shuxin Huang, Jingying Huang, et al.Asia-Pacific Journal of Clinical Oncology|February 8, 2020
Tumor volume and sphericity as predictors of local control after stereotactic radiosurgery for limited number (1-4) brain metastases from nonsmall cell lung cancerPeter Hansoo Ko, Hun Jung Kim, Jeong Shim Lee, et al.Asia-Pacific Journal of Clinical Oncology|February 8, 2020
Addition of short course radiotherapy in newly diagnosed locally advanced rectal cancers with distant metastasisShanu Jain, Reena Engineer, Vikas Ostwal, et al.Asia-Pacific Journal of Clinical Oncology|February 21, 2020
Comparison of S-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (XELOX) as adjuvant chemotherapies for stage II and III gastric cancer after D2 resection: A single-center retrospective studyZhichao Jiang, Yongkun Sun, Wen Zhang, et al.Pageof 157